Trial Profile
A long-term, open-label, safety extension study of the combination of Fenofibric Acid and statin therapy for subjects with mixed dyslipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2021
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary) ; Atorvastatin; Rosuvastatin; Simvastatin
- Indications Dyslipidaemias
- Focus Adverse reactions; Registrational
- Sponsors Abbott Laboratories
- 28 Jul 2009 Actual patient number (1911) added as reported by ClinicalTrials.gov.
- 12 Jun 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
- 04 Oct 2006 New trial record.